Aethlon Medical, Inc. (AEMD) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated June 26, 2025, serves as a current report for Aethlon Medical, Inc., a Nevada corporation headquartered in San Diego, California. The filing primarily discloses the Company's financial results for the quarter ended March 31, 2025, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) and are not explicitly detailed in the body of this Form 8-K.
Material Changes
No material changes versus the prior comparable period are described in the text of this filing. The document acts as a conduit to the press release containing the comparative financial analysis.
Guidance, Outlook, and Risks
The filing incorporates management commentary and results by reference to the June 26, 2025 press release. The document explicitly states that the information furnished under Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated. No specific risks, contingencies, or unusual items are detailed in the text of this report.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated June 26, 2025) for actual revenue, net loss, and cash position figures for the quarter ended March 31, 2025.
- Verify the Company's liquidity status and runway based on the cash flow data in the referenced press release.
- Confirm any updates to clinical trial progress or regulatory milestones mentioned in the press release.
- Note that the information in this 8-K is furnished, not filed, limiting its legal liability under Section 18 of the Exchange Act.